| abstract |
Compounds according to Formula (I); wherein the radical R7 preferably represents a hetereocycle of 6 or 7 members and R4, R9-12 all preferably represent hydrogen atoms. These compounds and their pharmaceutical acceptable salts are used in pharmaceutical compositions and are useful for treating serotonin 5HT2C receptor mediated diseases. Processes to make such derivatives are as well disclosed therein. |